Cargando…
Giant cell tumour of the bone treated with denosumab: How has the blood supply and oncological prognosis of the tumour changed?
BACKGROUND: Denosumab is gradually applied to refractory or unresectable giant cell tumour of the bone. Whether denosumab can effectively reduce the blood supply of tumour and bring benefit is worthy of study. The aim of the study is to evaluate the related changes after treatment: blood supply, sur...
Autores principales: | Niu, Xiaohui, Yang, Yongkun, Wong, Kwok Chuen, Huang, Zhen, Ding, Yi, Zhang, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Speaking Orthopaedic Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718948/ https://www.ncbi.nlm.nih.gov/pubmed/31508313 http://dx.doi.org/10.1016/j.jot.2018.10.003 |
Ejemplares similares
-
Study of imaging changes following preoperative denosumab for giant cell tumor of bone
por: Yang, Yongkun, et al.
Publicado: (2021) -
Radiological findings of denosumab treatment for giant cell tumours of bone
por: van Langevelde, Kirsten, et al.
Publicado: (2020) -
A nonrandomized controlled study of sacral giant cell tumors with preoperative treatment of denosumab
por: Yang, Yongkun, et al.
Publicado: (2018) -
The dilemma of denosumab: Salvage of a femoral head giant cell tumour
por: Gaston, Czar Louie, et al.
Publicado: (2014) -
The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone
por: Weschenfelder, Wolfram, et al.
Publicado: (2021)